Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Proteovista in September, 2019 for $224,527.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA236167-01A1 | Phase I | 224,527 | September 5, 2019 | |||||||
A SBIR Phase I contract was awarded to Proteovista in August, 2018 for $222,678.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA232913-01 | Phase I | 222,678 | August 6, 2018 | |||||||
A SBIR Phase I contract was awarded to Proteovista for $600,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93021C00055 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to Proteovista in September, 2014 for $643,400.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL118893-01A1 | Phase I | 643,400 | September 1, 2014 | |||||||
A SBIR Phase I contract was awarded to Proteovista for $297,818.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA163405-01 | Phase I | 297,818 | ||||||||
A SBIR Phase I contract was awarded to Proteovista for $218,168.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA159655-01A1 | Phase I | 218,168 | ||||||||
A SBIR Phase I contract was awarded to Proteovista in March, 2023 for $376,800.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HG012745-01 | Phase I | 376,800 | March 6, 2023 |